These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25801032)

  • 21. miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway.
    Wang L; Tang B; Han H; Mao D; Chen J; Zeng Y; Xiong M
    Cancer Biother Radiopharm; 2018 Feb; 33(1):32-38. PubMed ID: 29412697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.
    Gutierrez A; Sanda T; Grebliunaite R; Carracedo A; Salmena L; Ahn Y; Dahlberg S; Neuberg D; Moreau LA; Winter SS; Larson R; Zhang J; Protopopov A; Chin L; Pandolfi PP; Silverman LB; Hunger SP; Sallan SE; Look AT
    Blood; 2009 Jul; 114(3):647-50. PubMed ID: 19458356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN.
    Vivanco I; Palaskas N; Tran C; Finn SP; Getz G; Kennedy NJ; Jiao J; Rose J; Xie W; Loda M; Golub T; Mellinghoff IK; Davis RJ; Wu H; Sawyers CL
    Cancer Cell; 2007 Jun; 11(6):555-69. PubMed ID: 17560336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
    Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
    Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia.
    Gutierrez A; Grebliunaite R; Feng H; Kozakewich E; Zhu S; Guo F; Payne E; Mansour M; Dahlberg SE; Neuberg DS; den Hertog J; Prochownik EV; Testa JR; Harris M; Kanki JP; Look AT
    J Exp Med; 2011 Aug; 208(8):1595-603. PubMed ID: 21727187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis regulator through modulating IAP expression (ARIA) controls the PI3K/Akt pathway in endothelial and endothelial progenitor cells.
    Koide M; Ikeda K; Akakabe Y; Kitamura Y; Ueyama T; Matoba S; Yamada H; Okigaki M; Matsubara H
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9472-7. PubMed ID: 21593423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD.
    Yuan T; Yang Y; Chen J; Li W; Li W; Zhang Q; Mi Y; Goswami RS; You JQ; Lin D; Qian MD; Calin S; Liang Y; Miranda RN; Calin GA; Zhou X; Ma L; Zweidler-McKay PA; Liu B; Weng AP; Medeiros LJ; Zhang Y; You MJ
    Leukemia; 2017 Nov; 31(11):2355-2364. PubMed ID: 28280276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.
    Nakahata S; Ichikawa T; Maneesaay P; Saito Y; Nagai K; Tamura T; Manachai N; Yamakawa N; Hamasaki M; Kitabayashi I; Arai Y; Kanai Y; Taki T; Abe T; Kiyonari H; Shimoda K; Ohshima K; Horii A; Shima H; Taniwaki M; Yamaguchi R; Morishita K
    Nat Commun; 2014 Feb; 5():3393. PubMed ID: 24569712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
    Reed DE; Shokat KM
    Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The RhoA-ROCK-PTEN pathway as a molecular switch for anchorage dependent cell behavior.
    Yang S; Kim HM
    Biomaterials; 2012 Apr; 33(10):2902-15. PubMed ID: 22244698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of COX-2 and 5-LOX regulates the progression of colorectal cancer by promoting PTEN and suppressing PI3K/AKT pathway.
    Chang J; Tang N; Fang Q; Zhu K; Liu L; Xiong X; Zhu Z; Zhang B; Zhang M; Tao J
    Biochem Biophys Res Commun; 2019 Sep; 517(1):1-7. PubMed ID: 29339153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDM2 regulates hypoxic hypoxia-inducible factor 1α stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner.
    Joshi S; Singh AR; Durden DL
    J Biol Chem; 2014 Aug; 289(33):22785-22797. PubMed ID: 24982421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redox-sensitive oxidation and phosphorylation of PTEN contribute to enhanced activation of PI3K/Akt signaling in rostral ventrolateral medulla and neurogenic hypertension in spontaneously hypertensive rats.
    Wu KL; Wu CA; Wu CW; Chan SH; Chang AY; Chan JY
    Antioxid Redox Signal; 2013 Jan; 18(1):36-50. PubMed ID: 22746319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BMI1 promotes cardiac fibrosis in ischemia-induced heart failure via the PTEN-PI3K/Akt-mTOR signaling pathway.
    Yang W; Wu Z; Yang K; Han Y; Chen Y; Zhao W; Huang F; Jin Y; Jin W
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H61-H69. PubMed ID: 30359076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway.
    He Z; Gao Y; Deng Y; Li W; Chen Y; Xing S; Zhao X; Ding J; Wang X
    PLoS One; 2012; 7(4):e35926. PubMed ID: 22563417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia.
    Chen Y; Wang T; Du J; Li Y; Wang X; Zhou Y; Yu X; Fan W; Zhu Q; Tong X; Wang Y
    Cell Physiol Biochem; 2018; 47(3):981-993. PubMed ID: 29843123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells.
    Ma J; Sawai H; Ochi N; Matsuo Y; Xu D; Yasuda A; Takahashi H; Wakasugi T; Takeyama H
    Mol Cell Biochem; 2009 Nov; 331(1-2):161-71. PubMed ID: 19437103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia.
    Palomero T; Dominguez M; Ferrando AA
    Cell Cycle; 2008 Apr; 7(8):965-70. PubMed ID: 18414037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease.
    Long SH; He Y; Chen MH; Cao K; Chen YJ; Chen BL; Mao R; Zhang SH; Zhu ZH; Zeng ZR; Hu PJ
    J Dig Dis; 2013 Dec; 14(12):662-9. PubMed ID: 23962154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway.
    Guo Y; Chang H; Li J; Xu XY; Shen L; Yu ZB; Liu WC
    Apoptosis; 2015 Aug; 20(8):1109-21. PubMed ID: 26002438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.